More than 80 billion neurons, trillions of synapses and almost 6 kilometres of neural pathways: The brain is an anatomical masterpiece; it is our control centre, memory store, coordinator of thoughts and movement – and still puzzles science. In medicine, the focus is on neurodegenerative diseases such as Alzheimer's and Parkinson's, but also on cerebrovascular disorders such as strokes and brain tumours, notably glioblastoma.
IDH mutated gliomas are slow-growing brain tumors with a relatively good prognosis. A new study shows that many patients reveal measurable cognitive impairment in the first year after treatment.
Depression is not only a disease of the mind or the brain, a new study finds: a research team has revealed deep connections to abnormalities in the body's overall immune response.
Philips and Cortechs.ai have extended their collaboration to integrate AI-enabled quantitative neuroimaging analytics directly into MR systems. The partnership aims to provide radiologists with automated, objective measurements of brain structures and lesions to support diagnosis and monitoring of neurological conditions.
New hope for patients with neurological diseases: A combination of focused ultrasound and gene therapy enables targeted, nonsurgical control of seizure-relevant brain regions.
Researchers developed an AI-assisted brain atlas for visualization at microscopic detail using MRI scans. The tool could transform early detection of Alzheimer's and other neurological diseases.
During menopause, many women experience forgetfulness, trouble concentrating, and mental fatigue. A new review explores the link between brain changes during menopause and these symptoms.
Traditional diagnostic methods for epilepsy face significant limitations. A new clinical trial explores the potential of advanced brain monitoring to improve diagnosis and management of the condition.
Researchers identified a targeted way to protect the brain from harmful side effects of cranial radiation therapy, potentially preserving the quality of life for millions of brain cancer survivors.
Entering menopause at an earlier age is associated with an increased risk of dementia, a new study finds. The research also suggests a way for women to combat the cognitive decline.
Scientists have developed a new method to track the build-up of amyloid plaques – a key characteristic of Alzheimer’s disease – in real time – an important step forward towards new treatments.
At the EANS neurosurgery congress in Vienna, Italian medical imaging company Esaote presented I-Genius, a new open MRI system designed to provide real time checks during glioma surgery.
Scientists have shown for the first time that glioblastoma—the deadliest form of brain cancer—affects not just the brain but also erodes the skull, alters the makeup of skull marrow, and interferes with the body’s immune response.
New insights on the mechanisms that cause “brain fog” in Long Covid patients: Researchers use a specialized brain imaging technique to identify a potential biomarker and therapeutic target.
A new ultrasound helmet capable of influencing deep brain regions without surgery opens up new possibilities for neurological research and treatment of disorders such as Parkinson’s disease.
A biodegradable, electroconductive self-healing hydrogel combined with acupuncture could help restore motor function and protect brain neurons in Parkinson’s disease models.
After an infection with the coronavirus Sars-CoV-2, the virus is able to persist at low levels in the brainstem, new research finds. This helps explain some of the enduring neurological symptoms.
A new method to monitor blood flow in the brain helps neurosurgeons detect the risk of a stroke during surgery – and potentially prevent it. This could also be useful for other types of operations.
Using electrodes implanted in the brain, researchers observed specific brain waves that could serve as a biomarker for obsessive-compulsive disorder (OCD) and are an important step towards more targeted treatments.
The earlier Alzheimer's disease is detected, the more effective treatments become. Now, a Finnish study shows that signs related to Alzheimer’s may already be found in the brain in middle age.
